Wallace Brownlee, MBChB, PhD, FRACP


Implications of Ozanimod Discontinuation Data for MS Care

Dr Brownlee shares his advice and recommendations from national MS society on providing cognitive care for patients suffering from MS.

Lara Jehi, MD


Sparing the Hippocampus in Epilepsy Surgery: Critical Decisions for Outcome Optimization

Surgical treatment for epilepsy has been proven its effectiveness, and preoperative evaluation has sparked a debate: to spare or not to spare the hippocampus?

Manish Shah MD, MPH


Manish Shah MD, MPH: How Telemedicine Can Reduce ED Use in Dementia

The professor of emergency medicine at the University of Wisconsin-Madison School of Medicine and Public Health spoke about how telemedicine in senior living communities can effectively decrease ED use by individuals with dementia.

Rebecca Ichord, MD


Rebecca Ichord, MD: Addressing Pediatric Stroke With Thrombectomy and Thrombolysis

The director of the Pediatric Stroke Program at CHOP discussed the findings of a single-center study exploring the incidence of children presenting with acute arterial ischemic stroke who may have been eligible for mechanical thrombectomy.

Sabrina Paganoni, MD, PhD


AMX0035 in the ALS Treatment Paradigm: Sabrina Paganoni, MD, PhD

The investigator at the Healey & AMG Center for ALS at Massachusetts General Hospital spoke to the data backing the investigational AMX0035 in the treatment of ALS. [WATCH TIME: 3 minutes]

David Li, MD, FRCPC


CMSC 2021 Annual Meeting Takeaways: David Li, MD, FRCPC

With the CMSC 2021 annual meeting having wrapped up, the director of the Multiple Sclerosis/MRI Research Group at the University of British Columbia offered his perspective on this year’s conference. [WATCH TIME: 1 minute]

Amy Sullivan, PsyD, ABPP


Amy Sullivan, PsyD, ABPP: Interdisciplinary Care in MS

The director of behavioral medicine at the Mellen Center for MS Treatment and Research at Cleveland Clinic discussed the importance of interdisciplinary care and ways it can be incorporated for patients with multiple sclerosis.

Ian Maidment, PhD


Ian Maidment, PhD: Treating Sleep Problems in Those with Dementia

The senior lecturer in Clinical Pharmacy at Aston University talked about issues facing the medical community in treating those with dementia who have sleep problems.

Megan Garlapow, PhD


Looking to the Future of Stroke Care: Protection and Restoration

Interest in advancing research in stroke therapeutics has historically come in fits and starts. Now with intravenous tPA and thrombectomy in regular use, experts are looking to get a step ahead of the damage.

William Pass, DVM


Exploring CB1, CB2 in Various Neurological Conditions

Cannabinoids are being explored in a variety of conditions, ranging from Alzheimer disease to migraine.

Ravi Dukkipati, MD


Recommendations for RRMS Management

Ahmed Zayed Obeidat MD, PhD; Ravi Dukkipati, MD; and Gabriel Pardo, MD, FAAN, share key takeaways for clinicians treating RRMS.

Daphne Chylinski, PhD Student


Daphne Chylinski: Arousals During Sleep Are Strongly Linked to Alzheimer Disease Pathophysiology

Chylinski spoke about the relationship between the increased number of arousals during sleep and the pathogenesis of Alzheimer disease.

Erica Slaughter


Biofluid Biomarkers Hold Promise for the Future of Huntington Disease

Currently, there are no disease-modifying medications for Huntington disease and few interventions available to effectively alleviate symptoms, while the lack of indicators of pathobiological processes at the molecular level has limited the ability to prove efficacy and safety in clinical trials.

Dennis Selkoe, MD


Dennis Selkoe, MD: Current Challenges in Alzheimer Disease and Hope for the Future

Selkoe spoke to a number of topics in the Alzheimer space, including the challenges in the field and his excitement for the future.

Alon Avidan, MD


Alon Avidan, MD: Improving Narcolepsy Management

The director of the Sleep Disorders Center and vice-chair of the department of neurology at UCLA David Geffen School of Medicine detailed the greatest need in the management of narcolepsy

Gilbert L'Italien, PhD


Gilbert L'Italien, PhD: The Economic Impact of MIDAS Disability Grades in Migraine

The senior VP of Global Health Economics and Outcomes Research and Epidemiology at Biohaven Pharmaceuticals discussed the findings from a poster presentation on the economic impact of migraine disability at AHS 2020.

Silas Inman


Efficacy and Tolerability on Display by SRP-9003 Over 2 Years in LGMD2E

Over a 2-year period, SRP-9003 elicited sustained protein expression in muscle tissue and stabilized North Star Assessment for Dysferlinopathies scores.

Susan Hutchinson, MD


Susan Hutchinson, MD: The Potential of the Gepant Class in Acute Migraine

The director of the Orange County Migraine and Headache Center spoke about the adherence issues in acute migraine treatment and how the safety profile of investigational medications such as rimegepant and ubrogepant suggests they may be able to address them.

Neishay Ayub, MD


Neishay Ayub, MD: Stratifying SUDEP Risk

The Clinical Fellow in Neurophysiology and Epilepsy at Massachusetts General Hospital spoke about the implications of this assessment of SUDEP.

Elaine Wirrell, MD


The Approval of Fenfluramine for Treating Dravet Syndrome

Two experts explain the impact of the drug fenfluramine’s FDA approval in the treatment of Dravet syndrome.

Lynn Shaughnessy, PsyD, ABPP/CN


World Alzheimer Day 2019: Key Takeaways From Leaders in Alzheimer Disease and Dementia

In recognition of World Alzheimer Day, experts in Alzheimer disease and dementia share insight from the latest Alzheimer Disease International's yearly World Alzheimer Report.

Hao Huang, MD


A Shortage of Headache Medicine Physicians: How Trainees Can Get Involved

Our patients have a huge need for access to specialists, yet unfortunately, there is a huge shortage of headache specialists.

Huma Sheikh, MD


Huma Sheikh, MD: Complementary Approaches for Multimodal Migraine Treatment

The assistant professor of neurology at Mount Sinai Health System spoke about the recent trend toward approaching migraine in a more holistic fashion, and the incorporation of nonpharmacologic options for patients with the chronic headache condition.

Nancy Chiaravalloti, PhD


Nancy Chiaravalloti, PhD: Using Cognitive Rehab Tactics in Healthy Individuals

The director of Centers for Neuropsychology and Neuroscience Research, and Traumatic Brain Injury Research at Kessler Foundation discussed the use of cognitive rehabilitation techniques in healthy individuals.

Aristea S. Galanopoulou, MD, PhD


EEG Abnormalities in Acutely Ill Patients With COVID-19

Preliminary findings from a retrospective sample series in the Bronx, New York.

Stephen Hantus, MD


Stephen Hantus, MD: Acute Symptomatic Seizures

The Director of the cEEG and Epilepsy Consult Service at the Cleveland Clinic Epilepsy Center spoke about the cautious for physicians treating patients with acute symptomatic seizures.

Fernando L. Pagán, MD


Recent Advances in Movement Disorders: Fernando Pagan, MD

The course director of ATMRD 2023 provided perspective on the notable strides made in the movement disorder field, including the significant progress made in drug delivery. [WATCH TIME: 5 minutes]

Stephen Silberstein, MD


Stephen Silberstein, MD: Treating Medication Overuse Headache

The director of the Jefferson Headache Center at Jefferson University Hospital discussed the need for physicians to revisit how they treat patients with chronic migraine who have developed medication overuse headache.

© 2023 MJH Life Sciences

All rights reserved.